Turing Pharmaceuticals
Most Read
We went to opening night of the Martin Shkreli musical. Smirks abounded
Lawmakers look to prevent drug makers from thwarting generic competition
Shkreli’s old company is sued for breaching sales contract for Daraprim
Drug sales dropped precipitously after Shkreli’s Turing hiked price, senator says
Turing execs warned Martin Shkreli against price hike, lawyer says
‘Pow!’ ‘It will be huge.’ Emails show Shkreli’s team exulting at drug price hike
